Get Rid of Your Cancer Treatment Frustrations

August 25, 2022

This article was written by Dr. Omer Rashid, DVM, MSc Parasitology and published in Innovative Veterinary Care Journal.

---

Data Science can ensure you are on the right path toward remission

Cancer treatment can be frustrating. You get the patients on a treatment regimen that you think is likely to bring remissions, but the results are not in your favor. The clients have that worried look on their faces, and you have to think about how to deal with the situation.

Data science and AI are proving to be helpful in every field of life. These tools can be leveraged in veterinary medicine as well. Machine learning models can be trained with relevant data to predict the most suitable treatments. This means if you follow data-based recommendations, the percentage of remissions would be high – more than what you expect.

Data science has validated its worth by accurately optimizing shipping routes in real-time, evaluating athletes’ performance, preventing tax evasion, and predicting incarceration rates. Data science has already positively impacted the healthcare domain. There have been a lot of advancements that have helped in improving different medical procedures.

Veterinary medicine also has a lot to benefit from data science. You can improve your practices by incorporating this wonderful area of science into your day-to-day operations.

As far as cancer treatment is concerned, ImpriMed has made it convenient for veterinarians to reap the benefits of data science. Here is more about ImpriMed.

ImpriMed: Your partner in the fight against cancer

ImpriMed is currently offering canine lymphoma and leukemia drug response predictions. They have trained machine learning models with varied clinical data to be able to give you the best possible guidance.

Their approach toward delivering optimized drug prediction profiles involves live cancer cells and testing them for drug sensitivity. They feed the resulting data into their already trained AI models, which evolve further to give you the best possible drug response prediction.

ImpriMed started its journey with an exclusive repository of extensive clinical data, which is now growing every day. They are achieving more and more precision with their drug response predictions.

When you order a drug response prediction profile from ImpriMed you are not only helping your clinical remission success rates but also the cause of animal welfare. Since ImpriMed started its operations, more than 200 veterinary oncologists have ordered personalized drug response prediction profiles from the company. The company’s science is also peer-reviewed and published in reputable scientific journals.

Samples can be collected from the patient through the fine needle aspiration method and sent to ImpriMed. Within seven days of sample collection, you’ll receive the drug prediction profile.

In the News

How Artificial Intelligence Is Revolutionising Cancer Care for Pets

Pets Magazine
Learn More →

Artificial Intelligence Takes on Cancer: The Only AI Dr. Karyn Doesn’t Hate

Dogster
Learn More →

Comparative Oncology: Advances in Cancer Care from Pets to Humans

Pharmacy Times
Learn More →

Cancer Treatment Gets Personal: How Artificial Intelligence Is Taking the Guesswork Out of Common Canine Cancers

Dogster
Learn More →

Ilona Holcomb on How ImpriMed’s AI is Transforming Cancer Treatment for Pets and Humans

Biopharma Boardroom
Learn More →

From Dogs to Humans: AI-Powered Drug Response Prediction Technology Demonstrates Improved Clinical Outcomes in Oncology

Pharmacy Times
Learn More →

ImpriMed unveils cancer treatment forecast technology

MobiHealthNews
Learn More →

New research evaluates flow cytometry and PARR as diagnostic support for feline lymphoma

American Animal Hospital Association NEWStat®
Learn More →

Cell-sizing method for high-accuracy feline lymphoma characterisation in veterinary sciences

Veterinary Practice
Learn More →

Flow cytometry and clonality evaluation are effective for characterizing feline lymphoma

DVM360
Learn More →

ImpriMed: Providing Personalized Medicine For Pets With Blood Cancer Diseases In A $1+ Billion Market

Pulse 2.0
Learn More →

New AI Tool Guides Canine Cancer Treatment

Today's Veterinary Business
Learn More →

Artificial intelligence poised to transform veterinary care

AVMA News
Learn More →

New AI service offers personalized drug response predictions for canine patients with cancer

DVM360
Learn More →

Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology

TechCrunch
Learn More →

ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment

USA Today
Learn More →

Data Science Can Markedly Improve Cancer Treatment Outcomes — ImpriMed Shows You How

Innovative Veterinary Care Journal
Learn More →

How ImpriMed Can Help Increase Cancer Remissions, Grow Your Reputation and Level Up Your Revenue

Innovative Veterinary Care Journal
Learn More →

ImpriMed: A Breath of Fresh Air for Traditionally Onerous Cancer Treatment Journeys

Innovative Veterinary Care Journal
Learn More →

ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization

International Business Times
Learn More →

New AI Technology From ImpriMed Helps Improve Cancer Treatment Success Rates in Your Practice…and Fosters Better Relationships

Innovative Veterinary Care Journal
Learn More →

The latest and greatest in canine oncology treatment

DVM360
Learn More →

Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator

MedCity News
Learn More →

Be sure to improve your cancer treatment outcomes

Innovative Veterinary Care Journal
Learn More →

Early leukemia and lymphoma remissions in cats and dogs

Innovative Veterinary Care Journal
Learn More →

Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 3)

One Million by One Million
Learn More →

Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 2)

One Million by One Million
Learn More →

Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 1)

One Million by One Million
Learn More →

Technological advancement makes cancer treatment easier

Innovative Veterinary Care Journal
Learn More →

Novel veterinary oncologic treatments and diagnostics

dvm360
Learn More →

AI’s Computing Power Could Make Fusion Energy Practical

Lifewire
Learn More →

Don't Guess Your Pet's Condition, Treat It with ImpriMed

Startup to Follow
Learn More →

Interview with ImpriMed CEO & Co-Founder Sungwon Lim

IdeaMensch
Learn More →

This Test Might Make All The Difference When Fighting Lymphoma

Canine Cancer Alliance
Learn More →

ImpriMed: Fighting Cancer — From Dogs To Humans

Startup Thread
Learn More →

At Pear demo day, a who’s who of VCs, and plenty of fresh ideas

TechCrunch
Learn More →